Estrella Immunopharma Inc. (ESLA) — Net Asset Quality Index
Estrella Immunopharma Inc. (ESLA) has a Net Asset Quality Index of -407.3% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.82 Million minus total liabilities of $9.26 Million yields net assets of $-7.43 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read debt load of Estrella Immunopharma Inc. for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Estrella Immunopharma Inc. Net Asset Quality Index Over Time (2021–2025)
This chart shows how Estrella Immunopharma Inc.'s Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of June 2026, the index stands at -407.3%, representing net assets of $-7.43 Million against total assets of $1.82 Million USD. For live market cap and overall valuation, see market value of Estrella Immunopharma Inc..
Annual Net Asset Quality Index for Estrella Immunopharma Inc. (2021–2025)
The table below presents the year-by-year Net Asset Quality Index for Estrella Immunopharma Inc. from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check ESLA strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -326.3% | $-10.37 Million | $3.18 Million | $13.54 Million | ▼ -330.9 pp |
| 2024 | 4.6% | $143.73K | $3.14 Million | $3.00 Million | ▼ -91.4 pp |
| 2023 | 95.9% | $4.27 Million | $4.45 Million | $180.70K | ▲ +25.1 pp |
| 2022 | 70.8% | $7.07 Million | $9.99 Million | $2.92 Million | ▲ +91.9 pp |
| 2021 | -21.1% | $-1.04 Million | $4.92 Million | $5.96 Million | — |